To the Editor We agree with Dr Ebrahim and colleagues1 that reanalyses of clinical trial data provide an important opportunity to better understand trial results and that more independent reanalyses are needed. However, the estimate of the number of reanalyses published prior to March 9, 2014, reported by Ebrahim et al1 is incorrect, possibly by a substantial margin.
Platts-Mills TF, Jones CW. Reanalyses of Trial Results. JAMA. 2015;313(1):92–93. doi:10.1001/jama.2014.15627
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: